Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics for oncology and rare diseases.
095700 | KO
Overview
Corporate Details
- ISIN(s):
- KR7095700001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크, 강서구
- Website:
- http://www.genexine.com/
- Sector:
- Manufacturing
Description
Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-26 00:00 |
주요사항보고서(유무상증자결정)
|
Korean | 35.8 KB | ||
| 2022-09-21 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.5 MB | ||
| 2022-07-11 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2022-05-23 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2022-05-23 00:00 |
[기재정정]투자판단관련주요경영사항(GX-E4(지속형 빈혈 치료제)기술이전 계약체결)
|
Korean | 19.2 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | 1.5 MB | ||
| 2022-03-30 00:00 |
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2022-03-29 00:00 |
정기주주총회결과
|
Korean | 28.1 KB | ||
| 2022-03-29 00:00 |
본점소재지변경
|
Korean | 5.0 KB | ||
| 2022-03-29 00:00 |
대표이사변경
|
Korean | 10.7 KB | ||
| 2022-03-29 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 12.8 KB | ||
| 2022-03-29 00:00 |
주식매수선택권부여에관한신고
|
Korean | 17.5 KB | ||
| 2022-03-28 00:00 |
[기재정정]주주총회소집공고
|
Korean | 455.4 KB | ||
| 2022-03-24 00:00 |
투자판단관련주요경영사항(GX-E4(지속형 빈혈 치료제)기술이전 계약체결)
|
Korean | 13.3 KB |
Automate Your Workflow. Get a real-time feed of all Genexine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genexine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genexine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
